Entia
Hannah Rawlinson-Smith is a Clinical Trial Coordinator at Entia since January 2023. Prior to this role, Hannah worked as a Data Assurance & Quality Classifier at the Medicines and Healthcare products Regulatory Agency from November 2021 to December 2022. Hannah holds a Bachelor's degree in Biochemistry from the University of Exeter and completed a PGCE in Chemistry at the University of Bristol. Hannah also received a Bachelor of Science in Biochemistry from the University of Calgary after completing their education at St Mary Redcliffe and Temple School.
This person is not in any teams
Entia
Entia is a medical technology company that specializes in improving access to blood tests. Its featured products include Aptus, designed for haemoglobin and haematocrit and Affinity, designed for people with cancer to monitor their blood counts at home.The company is a multidisciplinary team spanning design, engineering, quality assurance,business development, and innovation.